vimarsana.com

Page 18 - கேய்சிங்கேர் ஆரோக்கியம் அமைப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

TOP 10: 2020 in review

The COVID-19 pandemic and the presidential election dominated the storylines throughout 2020, but there are other stories beyond those that had an impact on our region. Here is a look

Ava, Liam top baby names at Geisinger hospitals

Ava and Liam were the two most popular baby names of the year at Geisinger hospitals, Geisinger Health System announced Thursday. Liam climbed up one spot in 2020, beating out Noah to take the No. 1 spot for boys, while Ava passed Emma, Olivia, Harper, Charlotte and Amelia to take the No. 1 spot for girls. The health system said it delivered 4,945 babies as of Dec. 21, and that the rankings were based on names selected at five hospitals in Pennsylvania. Geisinger Wyoming Valley Medical Center in Plains Twp. delivered 1,749 babies. The top six girls’ names at that hospital were: Ava, Sophia, Madison, Ella, Luna and Harper.

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), (ABCL) - The Daily Biotech Pulse: Osmotica Faces Second FDA Rejection, UK Conditionally Approves AstraZeneca s Vaccine Candidate, Hepion NASH Data

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), (ABCL) - The Daily Biotech Pulse: Osmotica Faces Second FDA Rejection, UK Conditionally Approves AstraZeneca s Vaccine Candidate, Hepion NASH Data
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Why DermTech Stock Is Soaring Today | The Motley Fool

Author Bio Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries. Follow @keithspeights What happened Shares of DermTech (NASDAQ:DMTK) were soaring 25.4% higher as of 10:57 a.m. EST on Wednesday. The impressive jump came after the company announced that Geisinger Health System issued a positive medical benefit policy for the DermTech Pigmented Lesion Assay (PLA), a non-invasive genomic test for the early detection of melanoma. So what A positive coverage decision from a major health plan such as Geisinger should pave the way for DermTech s sales to grow. Investors are understandably excited about today s news.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.